Historical salary details - Mr. Yannis Morel, PhD, Member of the Executive Board, Executive Vice President and Chief Operating Officer, Innate Pharma - ADR
Mr. Yannis Morel, PhD has been the Member of the Executive Board, Executive Vice President and Chief Operating Officer of Innate Pharma - ADR since 06 May 2001 and his latest salary was 709.8 K. View his historical salary.
Mr. Yannis Morel, Phd
Member of the Executive Board, Executive Vice President and Chief Operating Officer
$ 709.8 K
Gross Remuneration
-
Current Company
Innate Pharma - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Innate Pharma - ADR | Member of the Executive Board, Executive Vice President and Chief Operating Officer | 709.8 K | - |
| 2022 | Innate Pharma - ADR | Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development | - | - |
| 2021 | Innate Pharma - ADR | Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development | 637.8 K | 7.8 % |
| 2020 | Innate Pharma - ADR | - | 591.8 K | 3.5 % |
| 2020 | Innate Pharma - ADR | Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development | 591.8 K | 3.5 % |
| 2019 | Innate Pharma - ADR | - | 571.7 K | 3.5 % |
| 2019 | Innate Pharma - ADR | - | 571.7 K | 3.5 % |
| 2019 | Innate Pharma - ADR | Member of the Executive Board, Executive Vice President, Product Portfolio Strategy and Business Development and Member of the Executive Committee | 571.7 K | 3.5 % |
| 2018 | Innate Pharma - ADR | - | 552.2 K | - |
| 2018 | Innate Pharma - ADR | - | 552.2 K | - |
| 2018 | Innate Pharma - ADR | Member of the Executive Board, Executive Vice President, Product Portfolio Strategy and Business Development and Member of the Executive Committee | 552.2 K | - |